A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma

P. Rougier, M. Ducreux, D. Kerr, B. I. Carr, E. François, A. Adenis, L. Seymour

    Research output: Contribution to journalArticlepeer-review

    32 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)500-502
    Number of pages3
    JournalAnnals of Oncology
    Volume8
    Issue number5
    DOIs
    Publication statusPublished - 1 May 1997

    Keywords

    • Chemotherapy
    • Hepatocellular carcinoma
    • Raltitrexed
    • Tomudex
    • Treatment outcome

    Cite this